Enanta Pharmaceuticals, Inc. (ENTA)
NASDAQ: ENTA · Real-Time Price · USD
8.23
-0.46 (-5.29%)
Nov 18, 2026, 4:00 PM EST - Market closed
Enanta Pharmaceuticals Employees
Enanta Pharmaceuticals had 120 employees as of September 30, 2025. The number of employees decreased by 11 or 8.40% compared to the previous year. That makes Enanta Pharmaceuticals the 30,302nd largest employer in the world and 3,850th in the United States.
Employees
120
Change (1Y)
-11
Growth (1Y)
-8.40%
Revenue / Employee
$525,008
Profits / Employee
-$568,733
Market Cap
239.98M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Sep 30, 2025 | 120 | -11 | -8.40% |
| Sep 30, 2024 | 131 | -14 | -9.66% |
| Sep 30, 2023 | 145 | -15 | -9.38% |
| Sep 30, 2022 | 160 | 5 | 3.23% |
| Sep 30, 2021 | 155 | 14 | 9.93% |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Vanda Pharmaceuticals | 533 |
| Rocket Pharmaceuticals | 202 |
| Cabaletta Bio | 158 |
| Allogene Therapeutics | 152 |
| Ocugen | 116 |
| Arcturus Therapeutics Holdings | 111 |
| Keros Therapeutics | 87 |
| Century Therapeutics | 78 |
ENTA News
- 11 hours ago - Enanta Pharmaceuticals Transcript: Jefferies Global Healthcare Conference - Transcripts
- 1 day ago - H.C. Wainwright sees ‘incremental disappointment’ in Enanta Q4 report - TheFly
- 2 days ago - Enanta Pharmaceuticals Reports Financial Results for its Fiscal Fourth Quarter and Year-Ended September 30, 2026 - Business Wire
- 2 days ago - Enanta Pharmaceuticals Earnings release: Q4 2026 - Filings
- 2 days ago - Enanta Pharmaceuticals Annual report: Q4 2026 - Filings
- 14 days ago - Enanta Pharmaceuticals to Participate in Upcoming Investor Conferences - Business Wire
- 21 days ago - Enanta announces retirement of CEO Luly, appoints Kieffer as COO - TheFly
- 21 days ago - Enanta Pharmaceuticals Announces Planned Retirement of Longstanding Chief Executive Officer Jay R. Luly, Ph.D. - Business Wire